Metraipolis › archive › dc_ad0f6c42f080

Investigating the impact of type I-E CRISPR-Cas systems and acrEI10 on multidrug-resistance in clinical isolates of Klebsiella pneumoniae — Europe PMC PMID:41259334

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41259334
DOI
10.1371/journal.pone.0335756
License (as archived)
solo-consultazione
Archived
2026-11-08T10:27:43.546Z
SHA-256 of the archived text
dbcdc05a8f79620c1e379dc128e6740b0444532668a1125a406c1f6454b53e3f
Stable URL of this page
https://metraipolis.com/documento/dc_ad0f6c42f080

How to cite

Investigating the impact of type I-E CRISPR-Cas systems and acrEI10 on multidrug-resistance in clinical isolates of Klebsiella pneumoniae — Europe PMC PMID:41259334 — Europe PMC (en), https://europepmc.org/article/MED/41259334 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ad0f6c42f080 (Metraipolis archive dc_ad0f6c42f080, sha256 dbcdc05a8f79620c1e379dc128e6740b0444532668a1125a406c1f6454b53e3f)
BibTeX
@misc{dcad0f6c42f080,
  title = {Investigating the impact of type I-E CRISPR-Cas systems and acrEI10 on multidrug-resistance in clinical isolates of Klebsiella pneumoniae — Europe PMC PMID:41259334},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41259334},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ad0f6c42f080; sha256 dbcdc05a8f79620c1e379dc128e6740b0444532668a1125a406c1f6454b53e3f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41259334. Agents can read the archived copy with the MCP tool read_document.